BindingDB logo
myBDB logout

BDBM50169896 3-{5-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-ylamino)-[1,3,5]triazin-2-yl]-pyridin-3-ylamino}-propan-1-ol::CHEMBL363590

SMILES: OCCCNc1cncc(c1)-c1ncnc(Nc2ccc3OCCOc3c2)n1

InChI Key: InChIKey=NDADSQVDVRXBPR-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50169896   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM50169896
PNG
(3-{5-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-ylamino)-[...)
Show SMILES OCCCNc1cncc(c1)-c1ncnc(Nc2ccc3OCCOc3c2)n1
Show InChI InChI=1S/C19H20N6O3/c26-5-1-4-21-15-8-13(10-20-11-15)18-22-12-23-19(25-18)24-14-2-3-16-17(9-14)28-7-6-27-16/h2-3,8-12,21,26H,1,4-7H2,(H,22,23,24,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents

Article
PubMed
n/an/a 4.14E+3n/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Inhibition of vascular endothelial growth factor receptor 2


J Med Chem 48: 4535-46 (2005)


Article DOI: 10.1021/jm040214h
BindingDB Entry DOI: 10.7270/Q2833RK0
More data for this
Ligand-Target Pair
Cyclin-dependent kinase 1


(Homo sapiens (Human))
BDBM50169896
PNG
(3-{5-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-ylamino)-[...)
Show SMILES OCCCNc1cncc(c1)-c1ncnc(Nc2ccc3OCCOc3c2)n1
Show InChI InChI=1S/C19H20N6O3/c26-5-1-4-21-15-8-13(10-20-11-15)18-22-12-23-19(25-18)24-14-2-3-16-17(9-14)28-7-6-27-16/h2-3,8-12,21,26H,1,4-7H2,(H,22,23,24,25)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents

Article
PubMed
n/an/a 344n/an/an/an/an/an/a



Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL


Assay Description
Inhibition of cyclin dependent kinase (CDK1)


J Med Chem 48: 4535-46 (2005)


Article DOI: 10.1021/jm040214h
BindingDB Entry DOI: 10.7270/Q2833RK0
More data for this
Ligand-Target Pair